When did GINKGO BIOWORKS HOLDINGS INC (DNA) report earnings last quarter?
GINKGO BIOWORKS HOLDINGS INC (DNA) last reported earnings on 2/26/2026.
GINKGO BIOWORKS HOLDINGS INC (DNA) Earnings History & Surprises
NYSE:DNA • US37611X2099
Current stock price
6.79 USD
+0.66 (+10.77%)
At close:
6.79 USD
0 (0%)
After Hours:
DNA Earnings overview
Past quarterly earnings results for GINKGO BIOWORKS HOLDINGS INC (DNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.09
- Revenue Estimate
- 41.865M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.41
- EPS Surprise
- 4.05%
- Revenue Surprise
- -10.85%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.41 | -1.47 | 4.05% | 29.50% | 33.396M | 37.461M | -10.85% | -23.84% |
| Q3 2025 | -1.45 | -1.25 | -15.78% | -54.26% | 38.837M | 39.239M | -1.02% | -56.39% |
| Q2 2025 | -1.10 | -1.58 | 30.48% | 60.71% | 49.604M | 42.026M | 18.03% | -11.75% |
| Q1 2025 | -1.68 | -1.79 | 6.02% | 47.50% | 48.318M | 39.083M | 23.63% | 27.34% |
| Q4 2024 | -2.00 | -1.79 | -11.88% | 54.55% | 43.847M | 44.909M | -2.36% | 26.16% |
| Q3 2024 | -0.94 | -2.75 | 65.88% | 85.31% | 89.046M | 45.45M | 95.92% | 60.65% |
| Q2 2024 | -2.80 | -3.15 | 11.14% | 22.22% | 56.206M | 43.568M | 29.01% | -30.24% |
| Q1 2024 | -3.20 | -3.37 | 4.95% | 27.27% | 37.944M | 46.504M | -18.41% | -52.98% |
| Q4 2023 | -4.40 | -3.91 | -12.66% | -22.22% | 34.755M | 42.927M | -19.04% | -64.64% |
| Q3 2023 | -6.40 | -3.46 | -84.83% | 60.98% | 55.43M | 48.557M | 14.15% | -16.52% |
| Q2 2023 | -3.60 | -3.41 | -5.72% | 79.07% | 80.568M | 72.296M | 11.44% | -44.28% |
| Q1 2023 | -4.40 | -3.64 | -21.01% | 63.33% | 80.702M | 72.397M | 11.47% | -52.08% |
| Q4 2022 | -3.60 | -8.43 | 57.28% | 90.91% | 98.3M | 89.547M | 9.77% | -33.80% |
| Q3 2022 | -16.40 | -11.96 | -37.14% | -583.33% | 66.4M | 60.959M | 8.93% | -14.43% |
| Q2 2022 | -17.20 | -1.75 | -882.56% | - | 144.6M | 78.402M | 84.43% | 231.65% |
| Q1 2022 | -12.00 | -1.35 | -791.18% | - | 168.4M | 106.74M | 57.77% | 281.86% |
| Q4 2021 | -39.60 | -1.75 | -2,162.17% | - | 148.5M | 95.755M | 55.08% | 362.62% |
| Q3 2021 | -2.40 | -1.41 | -69.73% | - | 77.6M | 46.208M | 67.94% | 483.46% |
| Q2 2021 | - | - | 43.6M | - | - | |||
| Q1 2021 | - | - | 44.1M | - | - | |||
| Q4 2020 | - | - | 32.1M | - | - | |||
| Q3 2020 | - | - | 13.3M | - | - | |||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
6.20%
Max EPS beat (4)
30.48%
Min EPS beat (4)
-15.78%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
7.45%
Max Revenue beat (4)
23.63%
Min Revenue beat (4)
-10.85%
Analysis
In the last 4 quarters, DNA has beaten EPS estimates in 3 out of 4 releases
DNA has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, DNA has beaten the EPS estimates by 6.2% on average.
In the last 4 quarters, DNA has beaten the revenue estimates by 7.4% on average.
Related analysis
GINKGO BIOWORKS HOLDINGS INC / DNA Earnings FAQ
Did DNA stock beat earnings estimates in the most recent quarter?
GINKGO BIOWORKS HOLDINGS INC (DNA) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often GINKGO BIOWORKS HOLDINGS INC beats earnings estimates?
In the last 4 quarters, GINKGO BIOWORKS HOLDINGS INC (DNA) has beaten EPS estimates in 3 out of 4 releases.